CAMBRIDGE, MA / ACCESS Newswire / May 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive interim data from a Phase 1/2 clinical study (NCT05972174) evaluating the safety and ...
The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna to help the company develop, test and license mRNA-based vaccines to combat ...
Highly pathogenic avian influenza, a type of "bird flu," has been detected in three counties, according to the Indiana DNR in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback